HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Grm, H. S. Articles by Banks, L. Search for Related Content PubMed PubMed Citation Articles by Grm, H. S. Articles by Banks, L. Agricola Articles by Grm, H. S. Articles by Banks, L.

Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent

International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34012 Trieste, Italy

Correspondence
Lawrence Banks
banks{at}icgeb.org

An important characteristic of the E6 proteins derived from cancer-associated human papillomaviruses (HPVs) is their ability to target cellular proteins for ubiquitin-mediated degradation. Degradation of the p53 tumour suppressor protein by E6 is known to involve the cellular ubiquitin ligase, E6-AP; however, it is presently not known how E6 targets the Drosophila discs large (Dlg) tumour suppressor and the membrane-associated guanylate kinase inverted (MAGI) family of proteins for degradation. By using an in vitro E6-AP immunodepletion assay, these targets were tested for degradation in a E6-AP-dependent manner. The data showed clearly that E6 can direct the degradation of Dlg and the MAGI family of proteins in the absence of E6-AP in this in vitro system. These results provide compelling evidence for the role of E6-associated ubiquitin ligases other than E6-AP in the degradation of certain E6 targets.

This article has been cited by other articles:

				B. Cooper, N. Brimer, and S. B. Vande Pol Human Papillomavirus E6 Regulates the Cytoskeleton Dynamics of Keratinocytes through Targeted Degradation of p53 J. Virol., November 15, 2007; 81(22): 12675 - 12679. [Abstract] [Full Text] [PDF]

				S. Topffer, A. Muller-Schiffmann, K. Matentzoglu, M. Scheffner, and G. Steger Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses J. Gen. Virol., November 1, 2007; 88(11): 2956 - 2965. [Abstract] [Full Text] [PDF]

				C. H. Storrs and S. J. Silverstein PATJ, a Tight Junction-Associated PDZ Protein, Is a Novel Degradation Target of High-Risk Human Papillomavirus E6 and the Alternatively Spliced Isoform 18 E6 J. Virol., April 15, 2007; 81(8): 4080 - 4090. [Abstract] [Full Text] [PDF]

				K. Handa, T. Yugawa, M. Narisawa-Saito, S.-i. Ohno, M. Fujita, and T. Kiyono E6AP-Dependent Degradation of DLG4/PSD95 by High-Risk Human Papillomavirus Type 18 E6 Protein J. Virol., February 1, 2007; 81(3): 1379 - 1389. [Abstract] [Full Text] [PDF]

				P. Kuballa, K. Matentzoglu, and M. Scheffner The Role of the Ubiquitin Ligase E6-AP in Human Papillomavirus E6-mediated Degradation of PDZ Domain-containing Proteins J. Biol. Chem., January 5, 2007; 282(1): 65 - 71. [Abstract] [Full Text] [PDF]

				M. Lagrange, S. Charbonnier, G. Orfanoudakis, P. Robinson, K. Zanier, M. Masson, Y. Lutz, G. Trave, E. Weiss, and F. Deryckere Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6 J. Gen. Virol., April 1, 2005; 86(4): 1001 - 1007. [Abstract] [Full Text] [PDF]